Cargando…
Cerebrospinal fluid mtDNA concentration is elevated in multiple sclerosis disease and responds to treatment
BACKGROUND: Mitochondrial dysfunction is increasingly recognized as an important feature of multiple sclerosis (MS) pathology and may be relevant for clinical disease progression. However, it is unknown whether mitochondrial DNA (mtDNA) levels in the cerebrospinal fluid (CSF) associate with disease...
Autores principales: | Leurs, Cyra E, Podlesniy, Petar, Trullas, Ramon, Balk, Lisanne, Steenwijk, Martijn D, Malekzadeh, Arjan, Piehl, Fredrik, Uitdehaag, Bernard MJ, Killestein, Joep, van Horssen, Jack, Teunissen, CE |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987988/ https://www.ncbi.nlm.nih.gov/pubmed/28294696 http://dx.doi.org/10.1177/1352458517699874 |
Ejemplares similares
-
Switching natalizumab to fingolimod within 6 weeks reduces recurrence of disease activity in MS patients
por: Leurs, Cyra E, et al.
Publicado: (2017) -
Plasma proteome in multiple sclerosis disease progression
por: Malekzadeh, Arjan, et al.
Publicado: (2019) -
Yeast Chromatin Mutants Reveal Altered mtDNA Copy Number and Impaired Mitochondrial Membrane Potential
por: Staneva, Dessislava, et al.
Publicado: (2023) -
Retinal atrophy in relation to visual functioning and vision-related quality of life in patients with multiple sclerosis
por: Balk, Lisanne J, et al.
Publicado: (2017) -
Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers
por: Coric, Danko, et al.
Publicado: (2017)